Concepts (51)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Respiratory Distress Syndrome, Newborn | 4 | 2024 | 79 | 1.390 |
Why?
|
| High-Frequency Ventilation | 1 | 2024 | 16 | 0.910 |
Why?
|
| Noninvasive Ventilation | 1 | 2024 | 31 | 0.870 |
Why?
|
| Infant, Low Birth Weight | 1 | 2023 | 163 | 0.810 |
Why?
|
| Airway Extubation | 1 | 2023 | 67 | 0.800 |
Why?
|
| Infant, Premature | 8 | 2024 | 798 | 0.790 |
Why?
|
| Oximetry | 2 | 2013 | 158 | 0.770 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2012 | 92 | 0.400 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2012 | 167 | 0.370 |
Why?
|
| Continuous Positive Airway Pressure | 2 | 2024 | 51 | 0.370 |
Why?
|
| Infant, Newborn | 8 | 2024 | 8064 | 0.340 |
Why?
|
| Oxygen | 1 | 2012 | 540 | 0.320 |
Why?
|
| Nose | 2 | 2024 | 92 | 0.250 |
Why?
|
| Intermittent Positive-Pressure Ventilation | 1 | 2024 | 9 | 0.230 |
Why?
|
| Bronchopulmonary Dysplasia | 2 | 2023 | 184 | 0.210 |
Why?
|
| Delivery Rooms | 2 | 2013 | 16 | 0.210 |
Why?
|
| Pulmonary Surfactants | 1 | 2023 | 43 | 0.210 |
Why?
|
| Birth Weight | 1 | 2023 | 334 | 0.190 |
Why?
|
| Machine Learning | 1 | 2023 | 213 | 0.180 |
Why?
|
| Masks | 1 | 2019 | 39 | 0.160 |
Why?
|
| Hypertension, Pulmonary | 1 | 2023 | 429 | 0.160 |
Why?
|
| Premature Birth | 1 | 2021 | 379 | 0.140 |
Why?
|
| Time Factors | 2 | 2013 | 6188 | 0.100 |
Why?
|
| Humans | 9 | 2024 | 122633 | 0.100 |
Why?
|
| Benzoquinones | 1 | 2006 | 19 | 0.070 |
Why?
|
| Lactams, Macrocyclic | 1 | 2006 | 18 | 0.070 |
Why?
|
| Doxorubicin | 1 | 2006 | 300 | 0.060 |
Why?
|
| Lymphoma | 1 | 2006 | 321 | 0.050 |
Why?
|
| Surface-Active Agents | 1 | 2023 | 31 | 0.050 |
Why?
|
| Intensive Care, Neonatal | 1 | 2023 | 54 | 0.050 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2006 | 713 | 0.050 |
Why?
|
| Prospective Studies | 1 | 2013 | 6012 | 0.050 |
Why?
|
| Dexamethasone | 1 | 2021 | 272 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2006 | 1229 | 0.040 |
Why?
|
| Gestational Age | 1 | 2023 | 1115 | 0.040 |
Why?
|
| Infant | 2 | 2023 | 12272 | 0.040 |
Why?
|
| Lung | 1 | 2023 | 1468 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2012 | 15916 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2019 | 1033 | 0.030 |
Why?
|
| Incidence | 1 | 2019 | 3040 | 0.020 |
Why?
|
| Pregnancy | 1 | 2021 | 7105 | 0.020 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2006 | 35 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2006 | 240 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2006 | 312 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2006 | 729 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2006 | 611 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2006 | 712 | 0.010 |
Why?
|
| Apoptosis | 1 | 2006 | 1782 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2006 | 3283 | 0.010 |
Why?
|
| Female | 1 | 2021 | 65117 | 0.010 |
Why?
|
| Mutation | 1 | 2006 | 5771 | 0.010 |
Why?
|